Overview

Anti-inflammatory Effect of Pre-operative Stimulation of the Cholinergic Anti-Inflammatory Pathway

Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
0
Participant gender:
All
Summary
Hypothesis: Prucalopride can mimic electrical stimulation of the abdominal vagus nerve and has an anti-inflammatory effect. Aims: In the present pilot study, the investigators want to evaluate the anti-inflammatory effect of prucalopride. The following aims are formulated: 1. to show that prucalopride has a similar inflammatory effect as abdominal vagus nerve stimulation (VNS) 2. to evaluate whether prucalopride leads to accelerated post-operative recovery
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Katholieke Universiteit Leuven
KU Leuven
Collaborator:
Universitaire Ziekenhuizen Leuven
Treatments:
Anti-Inflammatory Agents
Cholinergic Agents
Prucalopride
Criteria
Inclusion Criteria:

- patients undergoing partial or full resection of the pancreas due to a benign or
malignant tumor

Exclusion Criteria:

- adjuvant radiotherapy

- evident intra-abdominal inflammation (diagnosed by imaging and/or laboratory results,
including an abscess or cholecystitis)

- chronic pancreatitis

- pancreatic polypeptide producing endocrine tumor

- American Society of Anesthesiologists physical-health status classification (ASA-PS)>3

- Poorly regulated diabetes (>200 mg/dl (=11 mmol/l))